EPAS1 and neoplasm: This is further supported by data that mutating the FIH-1 target residue in HIF-2α did not increase its effect on HIF target genes or tumour growth in CCRCC cells, whereas substituting the equivalent residue in HIF-1α had a major effect (Yan et al, 2007).